More SpaceX stock is about to hit the market. Here’s what to know.
About 7% of SpaceX shares held by insiders are set to be made eligible for trading.
Similar Posts
Legal Battles Expected Over Corpus Christi’s Water Rate Referendum
Reservoirs have rebounded, but the fight over water isn’t over in Corpus Christi. The City Council has ordered a public referendum on a citizen-led petition that would sharply increase the price of water for industrial facilities during drought. The proposal is expected to face a litany of legal challenges before November’s election. It would add…
SEC to Keep Hands Off Shareholder Proposals, Worrying Activists
The top U.S. financial regulator on Friday made permanent its decision to cease judging whether companies may exclude shareholder resolutions from votes at annual meetings, leaving investor activists concerned about diminishing influence. In practice, the change announced by the U.S. Securities and Exchange Commission extends a freeze put in place last November on deciding whether…
How can AI scale our capabilities at work?
KRIS NARAYANAN: A rep for sure is not going to remember what they said to you last year. But now AI-enabled reps can actually remember what was proposed to you last year that you may have accepted or rejected so that they can personalize what’s presented to you. MATT WOOD: The number one question that…
Adjusted for Risk: Concurrent CEO on Nextgen Advisors, AI
Recorded live at Wealth Management EDGE, host Ryan Nauman welcomes Nate Lenz, co-founder and CEO of Concurrent, to discuss shifts in wealth management and the rise of NextGen advisors. Lenz explains Concurrent’s platform model supporting independent wealth managers by handling middle and back office functions while preserving advisor autonomy, and highlights growth to supporting over…
Helping Clients Align Their Capital To What’s REALLY Important When They Don’t Know What Is: Kitces & Carl 197
The value of financial planning often stems from helping clients realize their goals… both in the literal financial sense of managing cashflow and in the figurative sense of determining what those goals actually are. The former is often ‘just’ a question of good planning, but the latter takes continual time and investigation. Aspirations like owning…
Which Healthcare ETF Is the Better Buy: VanEck’s Pharma PPH or State Street’s Biotech XBI?
The VanEck Pharmaceutical ETF (PPH +1.90%) offers concentrated exposure to established global drugmakers and higher yields, while the State Street SPDR S&P Biotech ETF (XBI -0.01%) provides a diversified, higher-volatility play on smaller-cap biotechnology innovation. Both funds offer paths into the healthcare sector but serve very different roles in a diversified portfolio. One focuses on…
